Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19

ID Solutions2,000 enrolled

Overview

Constitution of a collection of SARS-CoV-2 RNA extracts from nasopharyngeal and saliva / sputum samples, from the same patients (paired samples), taken during the same consultation in an indication of detection of SARS-CoV-2 in with a view to developing tests / diagnostic tools for SARS-CoV-2.

In order to preserve their anonymity, the participant will be identified in a dedicated form by a unique identification number. An identification list of participants will be kept in the investigator's file. The investigator will ensure that the anonymity of each person participating in the research is guaranteed. The source documents are the original documents, data and files from which the data concerning the participant is reported in the Data set\_COLL001.xls form provided to the investigator which will serve as an observation notebook. The investigator must agree to allow direct access to research source data during monitoring, audit or inspection visits. The source data is for the most part computerized and accessible after authorization. The data will be transcribed into an Excel form Data set\_COLL001.xls pseudonymized form which will serve as an observation book. The data will be recorded and then transmitted to ID SOLUTIONS via the Data set\_COLL001.xls form provided to the investigator.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Respiratory Tract Infections

Interventions

saliva samplingOTHER

when the patient goes to the laboratory for a covid 19 diagnostic from a routine nasopharingeal sample, an additionnal sample of saliva is asked

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male, female adult * Patient with an indication for SARS-CoV-2 screening. * Patient having been informed and having given his non-objection to participate in the study * Patient affiliated with a French social security scheme or beneficiary of such a scheme Exclusion Criteria: * Pregnant or breastfeeding women * Vulnerable people Adults placed under tutorship or curatorship or under judicial protection, Patient unable to personally give consent, or adult protected by law, Opposition expressed to inclusion in the study.

Locations (1)

Bioaxiome

Nîmes, France

Outcomes

Primary Outcomes

collection of RNA extracted nasopharyngeal and saliva samples

n=130 positive n=130 negative RNA extracted from both nasopharyngeal and saliva samples from same patients sampled at the same time with suspicious COVID-19 will

Time frame: up to 1 month over which the samples of each participant are collected then tested

collection of RNA extracted nasopharyngeal and saliva samples

Collection of n=130 positive n=130 negative RNA extracted from both nasopharyngeal and saliva samples from same patients sampled at the same time with suspicious COVID-19 will enter the collection

Time frame: up to 1 month over which the samples of each participant are collected then tested

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.